Ambagon Therapeutics
Carolyn Bertozzi, Ph.D., is the Anne T. and Robert M. Bass Professor of Chemistry at Stanford University and an Investigator of the Howard Hughes Medical Institute. She is a member of the National Academy of Sciences, the National Academy of Medicine, and the National Academy of Inventors. Carolyn is a world leader in the study of glycoscience as it relates to various diseases including cancer, inflammation, and infectious disease.
This person is not in the org chart
This person is not in any offices
Ambagon Therapeutics
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.